Specifically, we investigated the interaction of SERCA2 haploinsufficiency with hypothyroidism, which is known to impair cardiac performance [13], and alterations in myofibrillar Ca2+-sensitivity, which causes pathological hypertrophy and heart failure [14, 15]. The gene discussed is ATP2A2; the disease is heart failure.